1. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. Issue 4 (1st April 1998) Authors: Gross, V; Andus, T; Ecker, K W; Raedler, A; Loeschke, K; Plauth, M; Rasenack, J; Weber, A; Gierend, M; Ewe, K; Schölmerich, J Journal: Gut Issue: Volume 42:Issue 4(1998) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Issue 2 (1st August 2000) Authors: von Baehr, V; Döcke, W-D; Plauth, M; Liebenthal, C; Küpferling, S; Lochs, H; Baumgarten, R; Volk, H-D Journal: Gut Issue: Volume 47:Issue 2(2000) Page Start: 281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration. Issue 6 (1st June 2000) Authors: Plauth, M; Roske, A-E; Romaniuk, P; Roth, E; Ziebig, R; Lochs, H Journal: Gut Issue: Volume 46:Issue 6(2000) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗